PubMed Health⌕ Search

PubMed · 10152486

'Stakes are even higher'.

Abstract

While Congress continues to debate how and where to slice more than $450 billion out of the future growth of the federal Medicare/Medicaid programs, the American Hospital Association is in the midst of an aggressive advocacy campaign intended to minimize the impact on America's hospitals and health systems. In an exclusive interview with the editors of Georgia Hospitals TODAY, American Hospital Association President Richard Davidson outlined AHA's efforts and goals during the legislative process and stressed the need for all hospitals to be involved in educating their legislative representatives.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R Davidson. 1995. 'Stakes are even higher'.. https://pubmed.ncbi.nlm.nih.gov/10152486/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Clinical trials update from the American Heart Association 2006: OAT, SALT 1 and 2, MAGIC, ABCD, PABA-CHF, IMPROVE-CHF, and percutaneous mitral annuloplasty.

This article provides information and a commentary on trials presented at the American Heart Association meeting held in November 2006, relevant to the pathophysiology, prevention and treatment of heart failure. All reports should be considered as preliminary data, as analyses may change in the final publication. The OAT study failed to show a benefit of PCI over optimal medical therapy in patients with persistent total occlusion of the infarct related artery following a myocardial infarction. In SALT 1 and 2, tolvaptan was found to correct hyponatraemia of various aetiologies; however, whether this has an impact on heart failure prognosis requires further evaluation. A placebo controlled study of myocardial implantation of skeletal myoblasts in patients with moderate to severe LVSD (MAGIC) showed equivocal/uncertain effects, long term follow-up data are awaited. The ABCD study which compared the ability of an invasive and a non-invasive test to identify patients at risk of arrhythmic events prior to ICD implantation, suggested that the two strategies were comparable, although the practical value of either test remains uncertain and the study had many major flaws. The PABA-CHF study hinted that pulmonary vein antrum isolation might be more effective than AV node ablation with bi-ventricular pacing for the treatment of patients with heart failure in atrial fibrillation. In IMPROVE-CHF, an NT-pro BNP guided treatment strategy was found to reduce the cost of managing patients with acute breathlessness.

American Hospital Association↗